Pillsbury Advises Thyme Care on Series E Funding Round Totaling More Than $125 Million
September 04, 2026
September 04, 2026
NEW YORK, Sept. 4 -- Pillsbury, a law firm, issued the following news release:
* * *
Pillsbury Advises Thyme Care on Series E Funding Round Totaling More Than $125 Million
Pillsbury advised Thyme Care, a nationally recognized oncology company, on its Series E funding round that raised more than $125 million.
Morgan Health led the round, with participation from strategic healthcare investors Humana and CVS Health Ventures and institutional inves . . .
* * *
Pillsbury Advises Thyme Care on Series E Funding Round Totaling More Than $125 Million
Pillsbury advised Thyme Care, a nationally recognized oncology company, on its Series E funding round that raised more than $125 million.
Morgan Health led the round, with participation from strategic healthcare investors Humana and CVS Health Ventures and institutional inves . . .